Blood News and Research

RSS

Maryland startup Rhemisphere signs agreement with UMB for right to commercialize Blink system

Maryland startup Rhemisphere, LLC has licensed a unique, "all-in-one" patient monitoring system invented by clinical researchers at the University of Maryland, Baltimore.

28 Apr 2010

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

28 Apr 2010

Researchers develop new diagnostic approach to fight against Chagas disease

Chagas disease is one of the most deadly parasitic diseases in the world. It affects more than 10 million people, primarily in the Americas. In South America alone it kills 50 000 people each year. A reliable and rapid diagnosis is the key in the battle against infection but until now, this has been next to impossible.

28 Apr 2010

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Children with sickle cell disease who also have lower blood oxygen levels while both asleep and awake are likely to have heart abnormalities, researchers at Washington University School of Medicine in St. Louis and other institutions have found.

28 Apr 2010

Transplanted pig cells may bring relief from insulin injections in type I diabetics

Living Cell Technologies, a New Zealand based biotechnology company that is investigating the use of living pig cells in the treatment of diabetes has now received $700,000 (US$500,000) grant from the Juvenile Diabetes Research Foundation International for further human trials.

28 Apr 2010

Myriad Genetics OnDose collection kit eliminates need for frozen sample handling

Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.

28 Apr 2010

ChronSeal multi-center study in Sweden and Norway finalized

The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.

28 Apr 2010

FIESTY acronym to improve cognitive function, reduce chances of developing dementia

As researchers learn more about how we age, they're finding that genetics are only half of the story when it comes to developing Alzheimer's disease.

28 Apr 2010

FDA issues warning over faulty components in external defibrillators

About 280,000 external defibrillators used worldwide in health care facilities, public places, or in the home may malfunction during attempts to rescue people in sudden cardiac arrest, the U.S. Food and Drug Administration warned today.

28 Apr 2010

Dietary MSC can help reset cell's biological clock to prevent development of breast cancer: Study

Usually when all else fails with a technical device, a "reset" button can be pressed, preventing a glitch from going any further. What if that could be done with threats to a person's health? Investigators from The Cancer Institute of New Jersey and the Environmental & Occupational Health Sciences Institute which is jointly administered by UMDNJ-Robert Wood Johnson Medical School and Rutgers, The State University of New Jersey, have discovered that a form of a dietary trace element known as selenium can help reset a cell's "biological clock" when it is disrupted by a chemical cancer-causing agent (carcinogen).

28 Apr 2010

Five-minute screening test could cut risk of developing bowel cancer: Research

A five-minute screening test could cut the risk of developing bowel cancer by a third and save thousands of lives from what is the UK's second biggest cancer killer, according to new research led by Imperial College London, published today in the Lancet.

28 Apr 2010

Laughter is truly the best medicine says new research

A new study has shown that laughter may be one of the simplest exercises that has similar effects on the body as pumping iron in the gym. Researchers have named “Laughercise” as significant elevators of mood, stress busters, immunity boosters and blood pressure and cholesterol reducers. It can also stimulate appetite for the malnourished.

28 Apr 2010

'Flexi-Scope' test reduces incidence of bowel cancer

A one-off screening test that takes just five minutes could reduce the risk of bowel cancer by one-third and save thousands of lives, UK scientists have said.

28 Apr 2010

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.

28 Apr 2010

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.

28 Apr 2010

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

The U.S. Food and Drug Administration today approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma in certain adults.

28 Apr 2010

Ranibizumab eye injections plus laser therapy result in dramatic visual improvement

Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.

28 Apr 2010

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

Cardiovascular Systems, Inc., has received Food and Drug Administration unconditional Investigational Device Exemption (IDE) approval, allowing the company to proceed with ORBIT II, a pivotal trial to evaluate the safety and effectiveness of CSI's Diamondback 360® System in the coronary arteries. CSI received conditional IDE approval for the ORBIT II study in January 2010.

28 Apr 2010

Whole grains in diet translate to multiple health benefits: says research

Whole grains in diet can protect an individual from heart diseases say the CSIRO Food Futures National Research Flagship scientists. According to Dr David Topping, the chef research scientist at CSIRO consumption of whole grains in cereal and breads can reduce the risk of several diseases like obesity, diabetes, high blood pressure, some cancers. Legumes and grains could also prevent asthma, gum disease etc.

27 Apr 2010

Reluctant Australian sperm donors forces fertility clinics to import from U.S.

With the shortage of sperm donors the Queensland Fertility Group, the largest fertility facility in Townsville has resorted to importing sperm from United States. This facility, some 1,300 Kilometers from Brisbane is reportedly paying $700-800 an ampule for the imported sperm. This is a new situation. Earlier the facility had a large number of donors of which a huge number were the university students but there has been a steady decline in donors with many north Queensland men, or even Australian men who are not prepared to donate.

27 Apr 2010

Blood News and Research

Maryland startup Rhemisphere signs agreement with UMB for right to commercialize Blink system

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Researchers develop new diagnostic approach to fight against Chagas disease

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Transplanted pig cells may bring relief from insulin injections in type I diabetics

Myriad Genetics OnDose collection kit eliminates need for frozen sample handling

ChronSeal multi-center study in Sweden and Norway finalized

FIESTY acronym to improve cognitive function, reduce chances of developing dementia

FDA issues warning over faulty components in external defibrillators

Dietary MSC can help reset cell's biological clock to prevent development of breast cancer: Study

Five-minute screening test could cut risk of developing bowel cancer: Research

Laughter is truly the best medicine says new research

'Flexi-Scope' test reduces incidence of bowel cancer

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

Ranibizumab eye injections plus laser therapy result in dramatic visual improvement

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

Whole grains in diet translate to multiple health benefits: says research

Reluctant Australian sperm donors forces fertility clinics to import from U.S.

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News